GlaxoSmithKline (GSK) and Save the Children have launched the 2nd annual Healthcare Innovation Awards in which organisations that deliver the most innovative ideas in tackling children health issues will share $1 million.
GSK, the giant global healthcare company and Save the Children, an international charity organisation, are now calling for entries for the awards that are aimed at helping improve survival rates of newborns and children under five in developing countries.
The call for entries for the 2014 awards comes just six month after five organisations in developing countries received the 2013 share of the cash price, which they are utilising in shape national health agendas and influencing approaches to healthcare for children and newborns.
It is estimated that each year almost three million babies die during their first month of life yet these deaths are preventable if the right resources and care are put in place.
In 2013, Friends of Sick Children in Malawi scooped the top prize of $400,000 for their life-saving technology for newborns.
The organisation has developed a low-cost device that helps newborn babies in respiratory distress to keep their lungs inflated so they can breathe more easily, thus saving hundreds of newborns.
Other winners were BRAC of Bangladesh that was awarded $300,000 for helping to improve women and children’s health in the slums of Sierra Leone, MUSO of Mali received $100,000 for delivering care to the doorsteps of some of the world’s most impoverished communities while MicroClinic Technologies of Kenya got $100,000 for helping Kenyan public sector healthcare go digital.
Kangaroo Foundation of Colombia was awarded $100,000 in special recognition of its work spreading the Kangaroo Mother Care Method (KMC) to improve the premature and low birth weight babies’ care.